For example, research on absorbable acoustic microrobots has shown that using a hydrophilic/hydrophobic bilayer structure and bubble cavity design enables stable propulsion during treatment, followed by hydrolytic degradation, significantly reducing the risk of long-term residuals ( From a translational perspective, several key issues must be addressed before nanorobots can enter clinical applications: immune compatibility, visualization capabilities, degradable metabolism, dosage control, and clearance mechanisms ( in vivo must be systematically resolved and standardized ( 4.2 Translation, regulation, and ethics For micro/nanorobot technology to successfully transition from the laboratory to clinical practice, it must undergo a rigorous translation process that includes meeting various requirements, from technical performance verification to compliance with ethical and regulatory standards

In those settings, the following codes were revised: initial nursing facility care (CPT 99304 99306)
Rajarethinam J, Ang LW, Ong J, Ycasas J, Hapuarachchi HC, Yap G, et al
Berthoux E, Fabien N, Chayvialle JA, Ninet J, Durieu I